Serum concentration of interleukin-10 in inflammatory bowel disease;Stėzenie interleukiny 10 w surowicy krwi w nieswoistych zapaleniach jelit

Advances in Clinical and Experimental Medicine

Volumn 12, Issue 6, 2003, Pages 717-721

  Woźniak Stolarska, Barbara ^a,b   Sajewicz, Zbigniew ^a   Błachut, Kataryzna ^a  

^a Kat/Klin Gastroenterol/Hepatol   (Poland)

^b NONE   (Poland)

Author keywords

Inflammatory bowel disease; Interleukin 10

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MONOCLONAL ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION; GENETIC REGULATION; GENOTYPE; HUMAN; IMMUNOMODULATION; INTESTINE SURGERY; INTESTINE WALL; MEDICAL ASSESSMENT; MICROTITER PLATE ASSAY; NORMAL VALUE; PATHOGENESIS; RISK ASSESSMENT; ULCERATIVE COLITIS;

ANIMALIA;

EID: 0347765966     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lügering N., Kucharzik T., Kraft M., Winde G., Sorg C., Stoll R., Domschke W.: Interleukin (IL)-13 and IL-4 are potent inhibitors of IL-8 secretion by human intestinal epithelial cells. Dig. Dis. Sci. 1999, 44, 3, 649-655.
2. Nielsen O. H., Kappen T., Ral'diger N., Horn T., Eriksen J., Kirman I.: Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig. Dis. Sci. 1996, 41, 1786-1793.
3. Leach M. W., Davidson N. J., Fort M. M., Powrie F., Rennick D. M.: The role of IL-10 in inflammatory bowel disease: "of mice and men". Toxicol. Pathol. 1999, 27, 1, 123-133.
4. Louis E., Ribbens C., Godon A., Franchimont D., De Groote D., Hardy N., Boniver J., Belaiche J., Malaise M.: Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflammed mucosa in inflammatory bowel disease. Clin. Exp. Immunol. 2000, 120, 2, 241-246.
5. Anand A. C., Adya C. M.: Cytokines and inflammatory bowel disease. Trop. Gastroenterol. 1999, 20, 3, 97-106.
6. Tagore A., Gonsalkorale W. M., Pravica V, Hajeer A. H., McMahon R., Whorwell P. J., Sinnott P. J., Hutchinson I. V.: Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999, 54, 4, 386-390.
7. Koss K., Satsangi J., Fanning G. C., Welsh K. I., Jewell D. P.: Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel disease and normal controls: diferential effects on production and allele frequencies. Genes Immun. 2000, 1, 185-190.
8. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., Eitner K., Epplen J. T.: The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis 2000, 21, 3578-3582.
9. Parkes M., Satsangi J., Jewell D.: Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin. Exp. Immunol. 1998, 113, 28-32.
10. Gasche C., Bakos S., Dejaco C., Tillinger W., Zakeri S., Reinisch W.: IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel. J. Clin. Immunol. 2000, 20, 362-370.
11. Ishizuka K., Sugimura K., Homma T., Matsuzawa J., Mochizuki T., Kobayashi M., Otsuka K., Tashiro K., Yamaguchi O., Asakura H.: Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 in the colonic mucosa of ulcerative colitis. Digestion 2001, 63, Suppl. 1, 22-27.
12. Niederau C., Backmerhoff F., Schumacher B., Niederau Ch.: Inflammatory Mediators and Acute Phase Proteins in Patients with Crohn's Disease and Ulcerative Colitis. Hepato-Gastroenterology 44, 1997, 90-107.
13. Hosokawa T., Kusugami K., Ina K., Ando T., Shinoda M., Imada A., Ohsuga M., Sakai T., Matsuura T., Ito K., Kaneshiro K.: Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease. J. Gastroenterol. Hepatol. 1999, 14, 10, 987-996.
14. Rennick D. M., Fort M. M.: Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278, 6, G829-G833.
15. Barbara G., Xing Z., Hogaboam C. M., Gauldie J., Collins S. M.: Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 2000, 46, 3, 344-349.
16. Blumberg R. S., Saubermann L. J., Strober W.: Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 1999, 11, 6, 648-656.
17. MacDonald T. T.: Effector and regulatory lymphoid cells and cytokines in mucosal sites. Curr. Top. Microbiol. Immunol. 1999, 236, 113-135.
18. Sands B. E.: Novel therapies for inflammatory bowel disease. Gastroenterol. Clin. North. Am. 1999, 28, 2, 323-351.
19. van Hogezand R. A., Verspaget H. W.: New therapies for inflammatory bowel disease: an update on chimeric anti-TNF antibodies and IL-10 therapy. Scand. J. Gastroenterol. 1997, Suppl. 223, 105-107.
20. Moore K.W., O'Garra A., De Waal-Malefyt R., Vieira P., Mosmann T. R.: Interleukin-10. Annu. Rev. Immunol. 1993, 11, 165-190.
21. Van der Poll T., Jansen J., Levi M., ten Cate H., ten Cale J. W., van Deventer S. J. H.: Regulation of interleukin-10 relase by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 1994, 180, 1985-1988.
22. Ishida H.: Clinical implication of IL-10 in patients with immune and inflammatory disease. Clin. Pathol. 1994, 42, 843-852.
23. Wereszczyńska U., Kamiński K.: Rola cytokin i czasteczek przylegania w ostrym zapaleniu trzustki. Gastroenterol. Pol. 2000, 5/6, 319-323.
24. Indaram A.V., Visvalingam V., Locke M., Bank S.: Mucosal cytokine production in radiation-induced procto-sigmoiditid compared with inflammatory bowel disease. Am. J. Gastroenterol. 2000, 95. 5, 1221-1225.
25. Greenwood Van Meerveld B., Tyler K., Keith J. C. Jr.: Recombinant human interleukin-11 modulates ion transport and mucosal inflammation in the small intestine and colon. Lab. Invest. 2000, 80, 8, 1269-1280.
26. Heresbach D., Semana G., Gosselin M., Bretagne M. G.: An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD). Eur. Cytokine Netw. 1999, 10, 1, 7-15.
27. Dejaco C., Reinisch W., Lichtenberger C., Waldhoer T., Kuhn I., Tilg H., Gasche C.: In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes leukocyte activation markers in inflammatory bowel disease. J. Investig. Med. 2000, 48, 449-456.
28. Papadakis K. A., Targan S. R.: Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 2000, 51, 289-298.
29. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., Remaut E.: Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000, 289, 5483, 1352-1355.